Physician profile
Matthew Bernstein
NPI 1689062432
$1,925.88
in general payments reported to CMS, 2019-2025
8 companies · $344 in 2025
The $344 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $517 · 2021: $260 · 2022: $103 · 2024: $702 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,045.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,239.82 | 2019-2025 | Augment Injectable, Hoffmann, Citrefix |
| Inari Medical, INC. | $194.81 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Kerecis Limited | $144.09 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Advanced Oxygen Therapy INC. | $143.08 | 2022-2024 | Topical Oxygen Chamber For Extremities |
| Organogenesis INC. | $88.88 | 2021-2022 | |
| Kci USA, INC. | $54.74 | 2019 | |
| Smith+Nephew, INC. | $42.66 | 2025 | Renasys Touch |
| Horizon Therapeutics Plc | $17.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Bernstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.